A History of Success,
and Foundation for the Future
BioCina’s Roots Run Deep
Our US FDA, EMA, and TGA approved site has a has a 40+ year history in successful development and manufacturing delivery. Through the journey from its origins as Bresagen, to Pfizer, to BioCina now, our people have personally walked the path from research and development to commercial manufacturing and are uniquely suited to guide your biologic from concept to approval. With the microbial, plasmid DNA, and mRNA modalities, BioCina has worked on over the past 15 years 60 different products with more than 30 global partners.
1982
Bresagen Ltd. spun out of the University of Adelaide
Original GMP facility was built
2003
2004
Facility licensed by the Australian TGA
Site acquired by Hospira
2006
2009
Installation of 750 L fermenter and 2,900 L refold tank
New large scale purification equipment
2012-13
2014
Hospira Technology Team of the Year (Pharma/Biologics)
$21M Facility upgrade approved
Pfizer acquires Hospira
Pfizer President’s Award
2015
2016
Facility upgrade completed
GMP warehouse and QC laboratory upgrades completed
2017
2018
Pfizer President’s Award
US-FDA Pre-approval and GMP inspection
Pfizer – Bridgewest agreement for sale of Adelaide site
2020
2021
BioCina Established CDMO Bridgewest Australia Biotech dba BioCina